Exploring Encanta: A New Drug That Could Transform Longevity
Cambrian's latest drug, Encanta, seeks to replicate the health benefits of exercise, potentially enhancing longevity and healthspan according to early research.
Editorial Staff Jun 18
Medicine
Latest Medicine stories from Life.
Moderna's Flu Vaccine Gains Favor with FDA Before Advisory Committee Meeting
In recent biotech developments, the FDA seems receptive to Moderna's flu vaccine as UniQure prepares to submit its Huntington's therapy for approval, and Eli Lilly acquires 4E Therapeutics.
Editorial Staff Jun 17
Jeremy Clarkson Reveals Aggressive Prostate Cancer Diagnosis Ahead of Show Release
In a recent announcement, Jeremy Clarkson disclosed his diagnosis of aggressive prostate cancer, sharing the news ahead of new episodes of Clarkson’s Farm.
Editorial Staff Jun 17
Exploring the Use of Apple Watch in Parkinson's Drug Trials
This edition of STAT Health Tech highlights the innovative application of Apple Watch technology in a clinical trial for a Parkinson's drug, among other topics.
Editorial Staff Jun 16
New HIV Preventive Drug Lenacapavir Set for Southern Africa Rollout
Lenacapavir, a newly approved HIV preventive treatment, promises over 99% protection with just two doses annually, marking a significant advancement in public health efforts.
Editorial Staff Jun 16
FDA Approves Colorado's Plan to Import Drugs from Canada
In a significant move, the FDA has approved Colorado's initiative to import prescription drugs from Canada, aiming to alleviate the financial burden on residents.
Editorial Staff Jun 15
Trump's Medicare Plan for Obesity Drugs Raises Concerns Over Longevity
Starting July 1, Medicare will provide GLP-1 weight-loss drugs at a cost of $50. While intended as a temporary measure, its permanence is questionable.
Editorial Staff Jun 15
Assessing the Implications of Lilly's Ajax Acquisition in the Context of Drug Shortages
The recent acquisition of Ajax by Lilly comes at a time when the healthcare sector faces significant challenges, including a shortage of syphilis medication and the approval of a new diabetes drug by Sanofi.
Editorial Staff Jun 15
FDA Approves Sanofi's Diabetes Drug for Pediatric Patients Amid Controversy
The FDA has granted approval for a Sanofi diabetes treatment aimed at young patients, following a contentious internal dispute within the agency.
Editorial Staff Jun 13
Dawn Zuidgeest-Craft: Pursuing Medicine at 73
At 73, Dawn Zuidgeest-Craft embarks on a remarkable journey into medical residency, challenging age norms in the field of medicine.
Editorial Staff Jun 13
Trump Administration Moves to Close Medicare Drug Price Negotiation Loophole
In a recent development, the Trump administration is taking measures to address a loophole in the negotiations surrounding Medicare drug prices.
Editorial Staff Jun 12
Blood Cancer United Takes Action to Acquire Discontinued Drug Luvelta for Patients
In an unusual decision, Blood Cancer United, a nonprofit organization, is purchasing the last supplies of Luvelta, a discontinued investigational cancer drug.
Editorial Staff Jun 12
Exploring New Frontiers in Obesity Medications and Peptide Treatments
The landscape of obesity medications is evolving, with new drugs entering the market and peptides gaining traction in treatment protocols. The FDA's decisions will be pivotal.
Editorial Staff Jun 11
Exploring the Expanding Role of GLP-1 Agonist Drugs
GLP-1 agonist medications, such as Mounjaro and Ozempic, are increasingly being recognized for their diverse applications, including potential use in treating substance abuse.
Editorial Staff Jun 11
Novartis Reinforces Commitment to Molecular Glue Approach
In recent biotech developments, Novartis has reaffirmed its focus on molecular glue strategies amidst rising drug costs for seniors and advancements in leukemia treatments.
Editorial Staff Jun 11
Medicare Advantage Payment System Creates Imbalance in Drug Plan Competition
The dynamics of competition among Medicare Part D plans are increasingly affected by the payment structure of Medicare Advantage plans, raising concerns about fairness.
Editorial Staff Jun 11
Federal Actions Highlight Impact of Rare Outcomes on Vaccine and Gender Care Perceptions
Recent developments, including a federal memo on alleged vaccine-related deaths and the establishment of a detransition clinic, illustrate how rare outcomes can shape public views on vaccine safety and gender care.
Editorial Staff Jun 11
The Future of Pharmaceutical Careers: Nature-Inspired Drug Design
As the pharmaceutical industry evolves, Tim Cernak's shift from Big Pharma to nature-inspired drug design highlights a new approach to developing therapies with fewer side effects.
Editorial Staff Jun 11
The Rising Costs of Publishing: A Case Study from Nature Medicine
Elizabeth Selvin reflects on the stark contrast in publication fees at Nature Medicine between 2025 and 2026, highlighting a significant financial burden for researchers.
Editorial Staff Jun 11
OB-GYN Group Releases New Vaccine Guidelines for Pregnant Women
The American College of Obstetricians and Gynecologists has introduced its own vaccine schedule for pregnant women, which differs from the recommendations of the CDC.
Editorial Staff Jun 10